Luciferase reporter bioassay of parathyroid hormone compounds

Details Luciferase reporter bioassay of parathyroid hormone compounds Luciferase reporter bioassay of parathyroid hormone compounds

1999-08-31

2004-04-13

Kemmerer, Elizabeth (Department: 1647)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C435S320100, C435S325000, C435S007210, C435S008000, C435S366000

Reexamination Certificate

active

06720153

ABSTRACT:

FIELD OF THE INVENTION
This invention is directed to a bioassay for determining the functionality of parathyroid hormone compounds. More particularly, this invention is directed to a bioassay wherein the compound to be tested is added to a culture of parathyroid hormone receptor expressing cells bearing a reporter gene under the transcriptional control of multiple c-AMP responsive elements. Still more particularly, this invention is directed to a bioassay wherein the compound to be tested is added to a culture of parathyroid hormone receptor expressing cells bearing a luciferase reporter gene under the transcriptional control of multiple c-AMP responsive elements.
BACKGROUND OF THE INVENTION
Human parathyroid hormone (hPTH) is an 84 amino acid protein which is a major regulator of calcium homeostasis. Parathyroid hormone-related protein (hPTHrP) is a 139 to 171 amino acid protein with N-terminal homology to hPTH. The N-terminal fragments of hPTH and hPTHrP, particularly those consisting of amino acids 1-34, retain the full biological activity of the parent hormone.
The biological activity of hPTH is reflected in the activation of two secondary messenger systems: G-protein coupled adenylyl cyclase (AC) and protein kinase C (PKC) activity. The N-terminal fragments hPTH(1-34)OH and hPTH(1-31)NH
2
have been demonstrated to be anabolic with respect to bone formation in humans and ovariectomized rats, respectively. This increase in bone growth has been demonstrated to be coupled with stimulation of adenylyl cyclase activity. Analogs of these N-terminal fragments have significant therapeutic potential for the treatment of physiological conditions associated with bone cell calcium regulation including hypocalcemia; osteoporosis; osteopenia; and disorders associated with osteoporosis and osteopenia such as hyperparathyroidism, hypoparathyroidism, and Cushings syndrome; glucocorticoid- and immunosuppressant-induced osteopaenia; and bone fracture and bone refracture repair.
To facilitate the discovery of efficacious hPTH analogs, a need exists for methods of determining the functionality of these analogs. Such a method should be simple, sensitive, and lend itself to automation so that a multiplicity of compounds can be rapidly screened.
SUMMARY OF THE INVENTION
This invention is directed to a bioassay for determining the functionality of a parathyroid hormone compound comprising
(a) adding the compound to a culture of parathyroid hormone receptor expressing cells bearing a reporter gene under the transcriptional control of multiple cAMP responsive elements; and
(b) measuring the change in expression of the reporter gene. Preferably, the change in reporter gene expression is compared to appropriate control levels of reporter gene expression. Appropriate controls which may be measured include, but are not limited to, expression in the absence of the parathyroid hormone compound and/or expression in the presence of a known parathyroid hormone receptor agonist. Parathyroid hormone receptor agonists include, but are not limited to, hPTH(1-34)OH and hPTH(1-31 )NH
2
.
The cells may be prokaryotic or eukaryotic cells. Preferably, the cells are mammalian cells. The cells may comprise an endogenous or heterologous nucleic acid encoding the parathyroid hormone receptor. Preferably, the cells comprise a heterologous nucleic acid encoding the parathyroid hormone receptor.
The number of cAMP responsive elements should be sufficient to drive expression within the cell of the reporter gene in the presence of cAMP. Preferably, the number of cAMP responsive elements is greater than about 10. More preferably, the number of cAMP responsive elements is about 16.
The reporter gene may encode a protein selected from, but not limited to, &bgr;-galactosidase, chloramphenicol acetyltransferase, &bgr;-glucuronidase, and luciferase. A preferred reporter gene encodes luciferase.


REFERENCES:
patent: 4508828 (1985-04-01), Lindall et al.
patent: 5298429 (1994-03-01), Evans et al.
patent: 5494806 (1996-02-01), Segre et al.
Huang, et al, 1996, J. Biol. Chem.52: 33382.*
Yu, et al, 1997, Endocrinol., 138: 3085.*
Zhengmin, H. et al. 1996, J. Biol. Chem. 271(52):33382-33389, esp. Fig. 2.*
Yu, X, et al. 1997, Endocrinol. 138(8): 3085-3092, esp. p. 3087 and 3090.*
Babichuk et al., In Vivo Regulation of Murine Granzyme B Gene Transcription in Activated Primary T Cells, The Journal of Biological Chemistry 271(28), 16485-16493 (1996).
Migeon et al., Regulation of cAMP-mediated Gene Transcription by Wild Type a Mutated G-protein alpha Subunits, The Journal of Biological Chemistry 269(46), 29146-29152 (1994).
Gao et al., Functional Importance of the Cyclic AMP Response Element-Like Decamer Motif in the CD8alpha Promoter, The Journal of Immunology 150(10), 4376-4385 (1993).
Himmler et al., Functional Testing of Human Dopamine D1 and D5 Receptors Expressed In Stable cAMP-Responsive Luciferase Reporter Cell Lines, Journal of Receptor Research 13(1-4), 79-94 (1993).
Castanon et al., Functional Coupling Of Human Adenosine Receptors To A Ligand-Dependent Reporter Gene System, Biochemical & Biophysical Research Communications 198(2), 626-631 (1994).
Reeck et al., “Homology” in Proteins and Nucleic Acids: A Terminology Muddle and a Way out of It, Cell, 50, 667 (1987).
Germain et al., Transcription induction of the human renin gene by cyclic AMP requires cyclic AMP response element-binding protein (CREB) and a factor binding a pituitary-specific trans-acting factor (Pit-1) motif, Journal of Biochem 316, 107-113 (1996).
Ghozi et al., Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions, Proc. Natl. Acad. Sci. 93, 1935-1940 (1996).
Tilly et al., Expression of Recombinant Human Follicle-Stimulating Hormone Receptor: Species-Specific Ligand Binding, Signal Transduction, and Identification of Multiple Ovarian Messenger Ribonucleic Acid Transcripts, Endocrinology 131(2) 799-806 (1992).
Taylor et al., The use of phosphorothioate-modified DNA in restriction enzyme reactions to prepare nicked DNA, Nucleic Acids Research 13(24, 8749-8764 (1985).
Pei et al., Regulation of the alpha Inhibin Gene by Cyclic Adenosine 3′,5′-Monophosphate after Transfection into Rat Granulosa Cells, Molecular Endocrinology 5(4), 521-534 (1991).
Stachowiak et al., Regulation of tyrosine hydorxylase gene expression in depolarized non-transformed bovine adrenal medullary cells: second messenger systems and promoter mechanisms, Molecular Brain Research 22, 309-319 (1994).
Saiki et al., Enzymatic Amplification of Beta-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell Anemia, Science 230, 1350-1354 (1985).
Sanger et al., DNA Sequencing with Chain-Terminating Inhibitors, Prco. Natl. Acad. Sci. 74(12) 5463-5467 (1977).
Spengler et al., Differential signal transduction by five splice variants of the PACAP receptor, Nature 365, 170-175 (1993).
Mullis et al., Specific Synthesis of DNA in Vitro via a Polymerase-Catalyzed Chain Reaction, Methods in Enzymology 155, 335-350 (1987).
Pines et al., Generation and Characterization of Human Kidney Cell Lines Stably Expressing Recombinant Human PTH/PTHrP Receptor: Lack of Interaction With A C-Terminal Human PTH Peptide, Endocrimology 135(4), 1713-1716 (1994).
Fluehmann B. et al., Parathyroid Hormone Responses of Cyclic AMP-, Serum-and Phorbol Ester-responsive Reporter Genes in Osteoblast-like UMR-106 Cells, Molecular and Cellular Endocrinology 139 (1998) 89-98.

Affiliated with

Also associated with

Rating

Luciferase reporter bioassay of parathyroid hormone compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Luciferase reporter bioassay of parathyroid hormone compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Luciferase reporter bioassay of parathyroid hormone compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3197346